Murine Irritation & Redness Relief (Naphazoline Hydrochloride)

Naphazoline, the active ingredient in Murine Irritation & Redness Relief, is an alpha‑adrenergic agonist presented as an ocular solution for topical eye use. It reduces ocular redness and irritation by constricting conjunctival blood vessels, providing rapid relief for patients with eye discomfort.

GNH USA supplies Murine Irritation & Redness Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under strict quality‑assured conditions, ensuring consistent potency and safety.

Naphazoline acts as an ocular decongestant to treat conditions involving conjunctival vasodilation.

- Ocular redness: diminishes visible redness by narrowing conjunctival blood vessels. - Eye irritation: alleviates discomfort caused by minor irritants or dryness. - Conjunctival hyperemia: reduces excessive blood flow and swelling in the conjunctiva.

Naphazoline may cause a range of ocular and systemic reactions.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Mild headache. - Dryness or foreign‑body feeling in the eye. - Temporary increase in intra‑ocular pressure (rare).

Serious or Rare Side Effects: - Allergic reaction such as eyelid swelling, rash, or itching. - Severe eye pain or vision loss. - Systemic hypertension or rapid heart rate. - Persistent corneal ulceration.

Use of Naphazoline requires attention to specific safety considerations.

- Pregnancy: safety not established; avoid unless benefits outweigh potential risks. - Breastfeeding: unknown; consider possible exposure to the infant. - Contact lens wearers: remove lenses before application and wait several minutes before reinserting. - Pre‑existing glaucoma or ocular hypertension: use with caution and under medical supervision. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Naphazoline may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of other ocular decongestants: additive vasoconstriction can lead to ischemia. - Systemic sympathomimetic drugs (e.g., pseudoephedrine): may increase blood pressure.

Moderate Interactions (Monitor Closely): - Topical anesthetic eye drops: heightened risk of corneal toxicity. - Antihistamine eye drops: may reduce overall efficacy of each product. - Beta‑blocker eye drops for glaucoma: monitor intra‑ocular pressure closely.